Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INCY | AMGN | CELG | GILD | BIIB |
| Company | Incyte Corp | Amgen Inc | Celgene Corp | Gilead Sciences Inc | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 66.22 | 337.03 | 108.01 | 84.39 | 200.57 |
| High | 66.95 | 338.70 | 108.59 | 84.65 | 204.18 |
| Low | 65.27 | 334.61 | 107.27 | 83.43 | 200.11 |
| Last | 66.82 | 335.95 | 108.24 | 83.90 | 201.44 |
| Change | +1.65 | +3.03 | +0.11 | +0.01 | +3.85 |
| % Change | +2.53% | +0.91% | +0.10% | +0.01% | +1.95% |
| Volume | 2,077,685 | 1,626,109 | 191,230,496 | 8,797,352 | 1,122,166 |
| 20-Day Average Volume | 1,872,064 | 1,760,680 | 16,188,930 | 6,694,888 | 828,423 |
| Previous Close | 65.17 | 332.92 | 108.13 | 83.89 | 197.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | No | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 64.51 | 329.59 | 108.17 | 80.07 | 201.60 |
| 20-Day Raw Stochastic | 86.04% | 84.75% | 63.25% | 89.62% | 63.34% |
| 20-Day Relative Strength | 58.59% | 57.67% | 64.69% | 71.87% | 45.22% |
| Weighted Alpha | +19.41 | +27.09 | +46.30 | +18.24 | -21.62 |
| Today's Opinion | 100% Buy | 96% Buy | 100% Buy | 88% Buy | 100% Sell |
| Previous Opinion | 100% Buy | 88% Buy | 100% Buy | 88% Buy | 100% Sell |
| Last Month's Opinion | 88% Buy | 88% Buy | 100% Buy | 56% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.46% since 09/12/24 | +1.78% since 09/12/24 | -1.97% since 11/13/19 | +0.89% since 09/12/24 | +1.79% since 09/12/24 |
| Low | 63.07 on 09/13/24 | 327.15 on 09/13/24 | 107.27 on 11/20/19 | 81.57 on 09/13/24 | 192.25 on 09/13/24 |
| High | 67.74 on 09/17/24 | 339.00 on 09/18/24 | 110.53 on 11/14/19 | 84.65 on 09/19/24 | 204.18 on 09/19/24 |
| 1-Month | |||||
| %Chg | +5.63% since 08/19/24 | +2.43% since 08/19/24 | +5.14% since 10/18/19 | +12.69% since 08/19/24 | -2.24% since 08/19/24 |
| Low | 61.15 on 09/05/24 | 319.00 on 09/06/24 | 102.40 on 10/21/19 | 74.34 on 08/20/24 | 192.25 on 09/13/24 |
| High | 67.74 on 09/17/24 | 339.00 on 09/18/24 | 110.70 on 11/13/19 | 84.89 on 09/12/24 | 207.59 on 08/21/24 |
| 3-Month | |||||
| %Chg | +8.76% since 06/18/24 | +9.79% since 06/18/24 | +13.63% since 08/20/19 | +32.86% since 06/18/24 | -9.93% since 06/18/24 |
| Low | 56.75 on 07/05/24 | 303.55 on 06/20/24 | 93.41 on 08/23/19 | 64.86 on 06/20/24 | 192.25 on 09/13/24 |
| High | 70.36 on 07/25/24 | 346.85 on 07/25/24 | 110.70 on 11/13/19 | 84.89 on 09/12/24 | 238.00 on 07/12/24 |
| 6-Month | |||||
| %Chg | +14.56% since 03/19/24 | +23.63% since 03/19/24 | +14.14% since 05/20/19 | +14.29% since 03/19/24 | -7.86% since 03/19/24 |
| Low | 50.35 on 04/30/24 | 260.68 on 04/19/24 | 89.08 on 07/23/19 | 62.07 on 05/31/24 | 189.44 on 04/19/24 |
| High | 70.36 on 07/25/24 | 346.85 on 07/25/24 | 110.70 on 11/13/19 | 84.89 on 09/12/24 | 238.00 on 07/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 14,633,336 | 178,589,936 | 77,035,920 | 104,514,608 | 28,768,510 |
| Shares Outstanding, K | 224,541 | 536,435 | 711,714 | 1,245,853 | 145,597 |
| Annual Sales | 3,695,650,000 | 28,190,000,000 | 15,281,000,000 | 27,116,000,000 | 9,835,600,000 |
| Annual Net Income | 597,600,000 | 6,717,000,000 | 4,046,000,000 | 5,665,000,000 | 1,161,100,000 |
| Last Quarter Sales | 1,043,760,000 | 8,388,000,000 | 4,520,000,000 | 6,954,000,000 | 2,464,900,000 |
| Last Quarter Net Income | -444,600,000 | 746,000,000 | 1,691,000,000 | 1,614,000,000 | 583,600,000 |
| 60-Month Beta | 0.73 | 0.61 | 1.41 | 0.18 | -0.06 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.82 on 07/30/24 | 4.97 on 08/06/24 | 2.99 on 10/31/19 | 2.01 on 08/08/24 | 5.28 on 08/01/24 |
| Latest Earnings Date | 10/29/24 | 10/29/24 | 10/31/19 | 11/05/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 830.37 | 17.89 | 10.99 | 17.67 | 12.19 |